Terms: = Uterine cancer AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1 AND Staging
1465 results:
1. Clinical Outcomes and Prognostic Factors in Stage III C Cervical cancer Patients Treated with Radical Radiotherapy or Radiochemotherapy.
Zhang W; Yu H; Xiu Y; Meng F; Wang Z; Zhao K; Wang Y; Chen Z; Liu J; Chen J; Sun B
Technol Cancer Res Treat; 2024; 23():15330338241254075. PubMed ID: 38720626
[No Abstract] [Full Text] [Related]
2. Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
Newton C; Graham R; Liberale V; Burnell M; Menon U; Mould T; Olaitan A; Macdonald N; Widschwendter M; Doufekas K; McCormack M; Mitra A; Arora R; Manchanda R
J Obstet Gynaecol; 2024 Dec; 44(1):2344529. PubMed ID: 38708782
[TBL] [Abstract] [Full Text] [Related]
3. SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.
Vázquez-Vicente D; Boria F; Castellanos T; Gutierrez M; Chacon E; Manzour N; Minguez JA; Martin-Calvo N; Alcazar JL; Chiva L;
Int J Gynecol Cancer; 2024 Feb; 34(2):203-208. PubMed ID: 38669163
[TBL] [Abstract] [Full Text] [Related]
4. PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer.
Albano C; Biolatti M; Mazibrada J; Pasquero S; Gugliesi F; Lo Cigno I; Calati F; Bajetto G; Riva G; Griffante G; Landolfo S; Gariglio M; De Andrea M; Dell'Oste V
Front Cell Infect Microbiol; 2024; 14():1359367. PubMed ID: 38529474
[TBL] [Abstract] [Full Text] [Related]
5. Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
Manning-Geist BL; Rios-Doria E; Liu YL; Ellenson LH; Zhou QC; Iasonos A; Leitao MM; Abu-Rustum NR; Weigelt B; Mueller JJ
Int J Gynecol Cancer; 2024 May; 34(5):697-704. PubMed ID: 38508587
[TBL] [Abstract] [Full Text] [Related]
6. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract] [Full Text] [Related]
7. Anatomical Distribution of Sentinel Lymph Nodes Harvested by Retroperitoneal vNOTES in 34 Consecutive Patients With Early-Stage Endometrial cancer: Analysis of 124 Lymph Nodes.
Huber D; Hurni Y
J Minim Invasive Gynecol; 2024 May; 31(5):438-444. PubMed ID: 38428574
[TBL] [Abstract] [Full Text] [Related]
8. Preoperative and postoperative staging in endometrial cancer - a prospective study.
Brych O; Drozenová J; Pichlík T; Hruda M; Rob L; Robová H; Waldauf P; Themistocleous P; Halaška MJ
Ceska Gynekol; 2024; 89(1):5-10. PubMed ID: 38418246
[TBL] [Abstract] [Full Text] [Related]
9. The Role of Lymphovascular Space Invasion and Cytology in the Prognosis of Endometrial cancer.
Ozdemir CY; Arioz DT; Celik F; Cicekli N; Chkhikvadze M; Bilir F; Yılmaz S; Vatansever N
Discov Med; 2024 Feb; 36(181):366-371. PubMed ID: 38409841
[TBL] [Abstract] [Full Text] [Related]
10. The significance of lower uterine segment involvement in endometrial cancer.
Davidesko S; Meirovitz M; Shaco-Levy R; Yarza S; Samueli B; Kezerle Y; Kessous R
Eur J Surg Oncol; 2024 Mar; 50(3):108007. PubMed ID: 38382274
[TBL] [Abstract] [Full Text] [Related]
11. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
[TBL] [Abstract] [Full Text] [Related]
12. SUrgical Access and Pattern of Recurrence of Endometrial cancer: The SUPeR Study, a Multicenter Retrospective Observational Study.
Puppo A; Migliaretti G; Landoni F; Uccella S; Camanni M; Ceccaroni M; Delpiano EM; Mantovani G; Roviglione G; Bianchi T; Grassi T; Maggi V; Garzon S; Galli L; Calandra V; Olearo E
J Minim Invasive Gynecol; 2024 Apr; 31(4):321-329. PubMed ID: 38301845
[TBL] [Abstract] [Full Text] [Related]
13. Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy.
Ma GF; Lin GL; Wang ST; Huang YY; Xiao CL; Sun J; Shi TY; Xiang LB
BMC Womens Health; 2024 Jan; 24(1):81. PubMed ID: 38297248
[TBL] [Abstract] [Full Text] [Related]
14. Effect of time interval between surgery and the initiation of adjuvant therapy on the oncologic outcomes of early-stage endometrial cancer.
Suphasynth Y; La-Orpipat T; Saeaib N; Janmunee N; Jiamset I
Int J Gynaecol Obstet; 2024 Jun; 165(3):1210-1217. PubMed ID: 38243580
[TBL] [Abstract] [Full Text] [Related]
15. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
Zhao D; Sun S; Yang Z; Wang P; Qiu H
Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
[TBL] [Abstract] [Full Text] [Related]
16. [Effects of preoperative diagnostic hysteroscopy on peritoneal cytology and prognosis in patients with non-endometrioid carcinoma].
Zhai ZY; Yang L; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):903-910. PubMed ID: 38123196
[No Abstract] [Full Text] [Related]
17. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
Wang J; Wang S; Wang J; Huang J; Lu H; Pan B; Pan H; Song Y; Deng Q; Jin X; Shi G
Cancer Med; 2023 Dec; 12(24):22381-22394. PubMed ID: 38087815
[TBL] [Abstract] [Full Text] [Related]
18. Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT database.
Vanbraband J; Van Damme N; Silversmit G; De Geyndt A; Bouche G; Jacomen G; de Jonge E; Goffin F; Denys H; Amant F
Gynecol Oncol; 2024 Jan; 180():70-78. PubMed ID: 38086166
[TBL] [Abstract] [Full Text] [Related]
19. Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.
Seino M; Nagase S; Tokunaga H; Yamagami W; Kobayashi Y; Tabata T; Kaneuchi M; Hirashima Y; Niikura H; Yoshino K; Takehara K; Baba T; Katabuchi H; Mikami M
J Gynecol Oncol; 2024 Jan; 35(1):e15. PubMed ID: 38037547
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of the diagnostic value of [
Lyu Y; Chen X; Liu H; Xi Y; Feng W; Li B
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1163-1172. PubMed ID: 38032383
[TBL] [Abstract] [Full Text] [Related]
[Next]
